Hendifar AE - Search Results

1

Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer.

Lurje G, Hendifar AE, Schultheis AM, Pohl A, Husain H, Yang D, Manegold PC, Ning Y, Zhang W, Lenz HJ. Lurje G, et al. Among authors: hendifar ae. Pharmacogenet Genomics. 2009 Feb;19(2):95-102. doi: 10.1097/FPC.0b013e32831a9ad1. Pharmacogenet Genomics. 2009. PMID: 18987561

2

Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer.

Lurje G, Zhang W, Yang D, Groshen S, Hendifar AE, Husain H, Nagashima F, Chang HM, Fazzone W, Ladner RD, Pohl A, Ning Y, Iqbal S, El-Khoueiry A, Lenz HJ. Lurje G, et al. Among authors: hendifar ae. Pharmacogenet Genomics. 2008 Feb;18(2):161-8. doi: 10.1097/FPC.0b013e3282f4aea6. Pharmacogenet Genomics. 2008. PMID: 18192902

3

Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer.

Lurje G, Zhang W, Schultheis AM, Yang D, Groshen S, Hendifar AE, Husain H, Gordon MA, Nagashima F, Chang HM, Lenz HJ. Lurje G, et al. Among authors: hendifar ae. Ann Oncol. 2008 Oct;19(10):1734-41. doi: 10.1093/annonc/mdn368. Epub 2008 Jun 11. Ann Oncol. 2008. PMID: 18550579 Free PMC article.

4

Gender disparities in metastatic colorectal cancer survival.

Hendifar A, Yang D, Lenz F, Lurje G, Pohl A, Lenz C, Ning Y, Zhang W, Lenz HJ. Hendifar A, et al. Clin Cancer Res. 2009 Oct 15;15(20):6391-7. doi: 10.1158/1078-0432.CCR-09-0877. Epub 2009 Sep 29. Clin Cancer Res. 2009. PMID: 19789331 Free PMC article.

5

Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity.

Yang D, Hendifar A, Lenz C, Togawa K, Lenz F, Lurje G, Pohl A, Winder T, Ning Y, Groshen S, Lenz HJ. Yang D, et al. J Gastrointest Oncol. 2011 Jun;2(2):77-84. doi: 10.3978/j.issn.2078-6891.2010.025. J Gastrointest Oncol. 2011. PMID: 22811834 Free PMC article.

6

POLE-Mutant Colon Cancer Treated with PD-1 Blockade Showing Clearance of Circulating Tumor DNA and Prolonged Disease-Free Interval.

Bikhchandani M, Amersi F, Hendifar A, Gangi A, Osipov A, Zaghiyan K, Atkins K, Cho M, Aguirre F, Hazelett D, Alvarez R, Zhou L, Hitchins M, Gong J. Bikhchandani M, et al. Genes (Basel). 2023 May 8;14(5):1054. doi: 10.3390/genes14051054. Genes (Basel). 2023. PMID: 37239414 Free PMC article.

7

Biomarker-driven EGFR therapy improves outcomes in patients with metastatic colorectal cancer.

Hendifar A, Tan CR, Annamalai A, Tuli R. Hendifar A, et al. Expert Rev Anticancer Ther. 2014 Sep;14(9):1051-61. doi: 10.1586/14737140.2014.922881. Epub 2014 Jun 5. Expert Rev Anticancer Ther. 2014. PMID: 24898788 Review.

8

Circulating tumor DNA dynamics and response to immunotherapy in colorectal cancer.

Gong J, Aguirre F, Hazelett D, Alvarez R, Zhou L, Hendifar A, Osipov A, Zaghiyan K, Cho M, Gangi A, Hitchins M. Gong J, et al. Mol Clin Oncol. 2022 May;16(5):100. doi: 10.3892/mco.2022.2533. Epub 2022 Mar 30. Mol Clin Oncol. 2022. PMID: 35463213 Free PMC article.

9

Review of systemic therapies for locally advanced and metastatic rectal cancer.

Yaffee P, Osipov A, Tan C, Tuli R, Hendifar A. Yaffee P, et al. J Gastrointest Oncol. 2015 Apr;6(2):185-200. doi: 10.3978/j.issn.2078-6891.2014.112. J Gastrointest Oncol. 2015. PMID: 25830038 Free PMC article. Review.

10

Redefining the Positive Margin in Pancreatic Cancer: Impact on Patterns of Failure, Long-Term Survival and Adjuvant Therapy.

Osipov A, Nissen N, Rutgers J, Dhall D, Naziri J, Chopra S, Li Q, Hendifar AE, Tuli R. Osipov A, et al. Among authors: hendifar ae. Ann Surg Oncol. 2017 Nov;24(12):3674-3682. doi: 10.1245/s10434-017-6076-z. Epub 2017 Sep 5. Ann Surg Oncol. 2017. PMID: 28871564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters